Freenome, Inc. Proceeds from Issuance of Private Placement
Freenome, Inc. (FRNM) reported Proceeds from Issuance of Private Placement of $0 for the 12-month period ending 2025-12-31, per its S-1 filed 2026-08-18.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-18
- Freenome, Inc. proceeds from issuance of private placement for the quarter ending 2025-12-31 was $0.00.
- Freenome, Inc. proceeds from issuance of private placement for the quarter ending 2025-09-30 was $0.00.
- Freenome, Inc. proceeds from issuance of private placement for the quarter ending 2025-06-30 was -$2.86M, a 200.00% decline year-over-year.
- Freenome, Inc. proceeds from issuance of private placement for the quarter ending 2025-03-31 was $2.86M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-08-18 | $0.00 derived: sum of 2 quarters · filed 2026-08-18 | -$2.86M derived: sum of 3 quarters · filed 2026-08-18 | $0.00 S-1 · filed 2026-08-18 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.86M derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-30 | -$2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-18 | $0.00 derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-31 | $2.86M 10-Q · filed 2025-05-12 | $2.86M derived: sum of 2 quarters · filed 2026-08-18 | $2.86M derived: sum of 3 quarters · filed 2026-08-18 | $5.72M derived: sum of 4 quarters · filed 2026-08-18 |
| 2024-12-31 | $0.00 derived: S-1 9 month − 10-Q 6 month · filed 2026-08-18 | $0.00 derived: sum of 2 quarters · filed 2026-08-18 | $2.86M S-1 · filed 2026-08-18 | |
| 2024-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-13 | $2.86M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $2.86M 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |